49 related articles for article (PubMed ID: 16499087)
21. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
22. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
[TBL] [Abstract][Full Text] [Related]
23. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
[TBL] [Abstract][Full Text] [Related]
24. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes.
Liu YT; Hao K; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2006 Sep; 27(9):1253-8. PubMed ID: 16923348
[TBL] [Abstract][Full Text] [Related]
26. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
[TBL] [Abstract][Full Text] [Related]
27. The In vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes.
Zhao XJ; Ishizaki T
J Pharmacol Exp Ther; 1997 Dec; 283(3):1168-76. PubMed ID: 9399990
[TBL] [Abstract][Full Text] [Related]
28. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat.
Swinney DC
Drug Metab Dispos; 1990; 18(6):859-65. PubMed ID: 1981529
[TBL] [Abstract][Full Text] [Related]
29. A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition.
Zhao XJ; Ishizaki T
Eur J Drug Metab Pharmacokinet; 1999; 24(3):272-8. PubMed ID: 10716067
[TBL] [Abstract][Full Text] [Related]
30. [Enzyme kinetics of schizandrin metabolism and sex differences in rat liver microsomes].
Xu MJ; Wang GJ; Xie HT; Huang Q; Jia YW
Yao Xue Xue Bao; 2007 Jul; 42(7):730-4. PubMed ID: 17882956
[TBL] [Abstract][Full Text] [Related]
31. [In vitro metabolism of forscolin isolated from Coleus forskohlii].
Zhang M; Meng ZY; Zhu XX; Dou GF
Yao Xue Xue Bao; 2013 Mar; 48(3):383-9. PubMed ID: 23724652
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cytochrome CYP2C19 on the anti-myeloma activity of thalidomide in vitro].
Li YH; Hou J; Jiang H; Huang HM; Zhu R
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):654-7. PubMed ID: 19176055
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and pharmacokinetics of the cardiotonic agent piroximone and of its major metabolite in dog.
Berg-Candolfi M; Dulery B; Jehl F; Haegele KD
Xenobiotica; 1995 Jan; 25(1):59-70. PubMed ID: 7604607
[TBL] [Abstract][Full Text] [Related]
34. Citalopram
Rochat B; Paus E; Maitre C; Baumann P
Vet Med (Praha); 2023 Apr; 68(4):135-144. PubMed ID: 37982088
[TBL] [Abstract][Full Text] [Related]
35. Aspirate of an elbow mass in a Beagle dog.
Irizarry-Rovira AR; Bough D; Berg D; DeNicola D; Christian J
Vet Clin Pathol; 2000; 29(4):129-131. PubMed ID: 12070823
[No Abstract] [Full Text] [Related]
36. Erratum in: Establishment of a Beagle Dog Model of Dry Eye Disease.
Transl Vis Sci Technol; 2024 Mar; 13(3):27. PubMed ID: 38547122
[No Abstract] [Full Text] [Related]
37. [Metabolic kinetics of MN9202 in Beagle dog liver microsomes].
Yang ZF; Zhou SY; Mei QB; Yang TH; Liu ZG
Yao Xue Xue Bao; 2005 Nov; 40(11):1019-23. PubMed ID: 16499087
[TBL] [Abstract][Full Text] [Related]
38. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes.
Liu XQ; Ren YL; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2000 Aug; 21(8):690-4. PubMed ID: 11501176
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
[TBL] [Abstract][Full Text] [Related]
40. [Metabolic kinetic of puerarin in beagle liver microsomal by HPLC-ESI-MS].
Wen BY; Li H; Wang L; Wang SC
Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(23):2834-7. PubMed ID: 19260325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
